enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Antiarrhythmic agent - Wikipedia

   en.wikipedia.org/wiki/Antiarrhythmic_agent

   Antiarrhythmic agents, also known as cardiac dysrhythmia medications, are a class of drugs that are used to suppress abnormally fast rhythms (tachycardias), such as atrial fibrillation, supraventricular tachycardia and ventricular tachycardia.

3. Ventricular fibrillation - Wikipedia

   en.wikipedia.org/wiki/Ventricular_fibrillation

   Ventricular fibrillation (V-fib or VF) is an abnormal heart rhythm in which the ventricles of the heart quiver. [2] It is due to disorganized electrical activity. [2] Ventricular fibrillation results in cardiac arrest with loss of consciousness and no pulse. [1] This is followed by sudden cardiac death in the absence of treatment. [2]

4. 8 Common Cardiovascular Diseases for Men & How to Prevent Them

   www.aol.com/8-common-cardiovascular-diseases-men...

   The main cause of cardiac arrest is two types of arrhythmias called ventricular fibrillation or ventricular ... The most common treatments are medications and surgery to repair the damaged blood ...

5. Bretylium - Wikipedia

   en.wikipedia.org/wiki/Bretylium

   The dose is 5–10 mg/kg and side effects are high blood pressure followed by low blood pressure and ventricular ectopy. Originally introduced in 1959 for the treatment of hypertension. [2] Its use as an antiarrhythmic for ventricular fibrillation was discovered and patented by Marvin Bacaner in 1969 at the University of Minnesota. [3]

6. Amiodarone - Wikipedia

   en.wikipedia.org/wiki/Amiodarone

   Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of cardiac dysrhythmias. [4] This includes ventricular tachycardia, ventricular fibrillation, and wide complex tachycardia, atrial fibrillation, and paroxysmal supraventricular tachycardia. [4]

7. Potassium channel blocker - Wikipedia

   en.wikipedia.org/wiki/Potassium_channel_blocker

   Sotalol is indicated for the treatment of atrial or ventricular tachyarrhythmias, and AV re-entrant arrhythmias. Ibutilide is the only antiarrhythmic agent currently approved by the Food and Drug Administration for acute conversion of atrial fibrillation to sinus rhythm. Azimilide; Bretylium; Clofilium; E-4031; Nifekalant [6] Tedisamil; Sematilide